Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LF.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDVORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDVENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDVENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDVNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KS.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KS.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KS.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KS.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
MK.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
MK.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
MK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MK.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.4.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.4.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.4.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.4.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LB.1.7.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LB.1.7.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1.7.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.7.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.42.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.42.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.42.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.42.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LA.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LA.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LF.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
LF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDV.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used